Former Xellia CEO becomes chairman of biotech company on capital hunt
Zerion Pharma, which focuses on improving the efficacy of existing drugs by increasing the solubility of oral medications, has a new chairman.
Read the whole article
Get access for 14 days for free. No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.
With your free trial you get:
Get full access for you and your coworkers
Start a free company trial todayRelated articles
Xellia chair on CEO switch: "We need other competencies"
For subscribers
Hovione enters partnership with Zerion Pharma
For subscribers